BioCentury
ARTICLE | Clinical News

Afstyla regulatory update

January 13, 2017 8:48 PM UTC

The European Commission approved an MAA from CSL for Afstyla lonoctocog alfa for treatment and prophylaxis of bleeding in patients with hemophilia A. CSL plans to launch Afstyla in Europe “in the comi...

BCIQ Company Profiles

CSL Ltd.